Thursday, March 21st | 14 Adar II 5779

March 7, 2019 11:15 am

aMoon2 Raises $660 Million, Becomes Largest Israeli Venture Capital Firm

avatar by

Email a copy of "aMoon2 Raises $660 Million, Becomes Largest Israeli Venture Capital Firm" to a friend

Yair Schindel, co-founder and managing partner of aMoon. Photo: Tomer Jacobson. – Israeli health fund aMoon2 has raised $660 million, becoming the Jewish state’s largest venture capital firm.

Out of an estimated $1 billion in assets under management on aMoon’s investment platform, the goal of aMoon2, which launched in 2018, is to “harness untapped Israeli HealthTech innovation and capitalize on mid-late stage funding gaps in Israel and around the world. To date, the fund has invested in four Israeli companies and a fifth in Silicon Valley, founded by an Israeli entrepreneur,” according to a company statement.

The initial aMoon fund was founded in 2016 by Marius Nacht, co-founder and chairman of Check Point Software Technologies, and Yair Schindel.

Israel’s electronic medical records account for 98 percent of the population, going back two decades. The Israeli government recently launched a national project that will invest $272 million in digital health initiatives over the next five years.

Related coverage

March 21, 2019 11:57 am

Korea’s BioLeaders To Invest $10 Million in Israel’s Weizmann Institute Anti-Cancer Therapy

CTech - Yongin, South Korea-headquartered biomedical company Bioleaders is looking to Israeli research institute the Weizmann Institute of Science for...

“The convergence of medicine and technology is generating a wave of innovation capable of redefining medical care—beyond our imagination,” said aMoon’s anchor investor Marius Nacht, co-founder and chairman of cybersecurity company Check Point Software Technologies. “This presents a unique opportunity both for impacting human life and for the investor community.”

Credit Suisse and aMoon announced in May 2018 a strategic partnership to enable investors with direct access to Israel’s rapidly growing health-tech sector.

“We believe our partnership with aMoon represents an attractive platform for investors, while providing the funding needed for disruptive businesses to drive the advancement of health care,” said Michel Degen, CEO of Credit Suisse Asset Management Switzerland and EMEA.

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner